3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
5
Ototoxicity
4
Medulloblastoma
4
Hepatoblastoma
4
Central Nervous System Neoplasms
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Drug-Related Side Effects and Adverse Reactions
3
Testicular Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Oligodendroglioma
2
Neoplasms, Germ Cell and Embryonal
2
Liver Neoplasms
2
Hearing Loss
2
Glioma
2
Brain Neoplasms
2
Astrocytoma
2
Adrenocortical Carcinoma
2
Thrombocytopenia
1
Teratoma
1
Seminoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Interventions
Cyclophosphamide
10
Doxorubicin
9
Vincristine
7
Etoposide
7
Ifosfamide
6
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Irinotecan
3
Cisplatin
3
Carboplatin
3
Brachytherapy
3
seclidemstat
2
Tacrolimus
2
PM 01183
2
Neoadjuvant Therapy
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
thymoglobulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Desmoplastic Small Round Cell Tumor
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled